Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Traws Pharma (TRAW)
NASDAQ:TRAW
Holding TRAW?
Track your performance easily
TRAW Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$4.44 - $27.50
Previous Close$5.41
Volume11.28K
Average Volume (3M)10.32K
Market Cap
$16.37M
Enterprise Value$16.37M
Total Cash (Recent Filing)$0.00
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
Beta1.50
Next Earnings
Nov 13, 2024EPS Estimate
-$6.25Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-138.17
Shares Outstanding3,025,430
10 Day Avg. Volume8,029
30 Day Avg. Volume10,324
Standard Deviation0.36
R-Squared0.04
Alpha-0.01
Financial Highlights & Ratios
Price to Book (P/B)-0.17
Price to Sales (P/S)72.42
Price to Cash Flow (P/CF)-0.40
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue72.10
Enterprise Value/Gross Profit72.42
Enterprise Value/Ebitda-0.12
Forecast
1Y Price Target
$7.00Price Target Upside18.65% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
Traws Pharma News
PremiumCompany Announcements
Traws Pharma Faces Uncertain Future Amid Complex Onconova Merger
PremiumCompany Announcements
Traws Pharma Reports Promising Antiviral Drug Progress
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
TRAW FAQ
What was Traws Pharma’s price range in the past 12 months?
Traws Pharma lowest stock price was $4.44 and its highest was $27.50 in the past 12 months.
What is Traws Pharma’s market cap?
Currently, no data Available
When is Traws Pharma’s upcoming earnings report date?
Traws Pharma’s upcoming earnings report date is Nov 13, 2024 which is 10 days ago.
How were Traws Pharma’s earnings last quarter?
Traws Pharma released its earnings results on Aug 15, 2024. The company reported -$121.75 earnings per share for the quarter, missing the consensus estimate of -$6.25 by -$115.5.
Is Traws Pharma overvalued?
According to Wall Street analysts Traws Pharma’s price is currently Undervalued.
Does Traws Pharma pay dividends?
Traws Pharma does not currently pay dividends.
What is Traws Pharma’s EPS estimate?
Traws Pharma’s EPS estimate is -$6.25.
How many shares outstanding does Traws Pharma have?
Traws Pharma has 3,025,431 shares outstanding.
What happened to Traws Pharma’s price movement after its last earnings report?
Traws Pharma reported an EPS of -$121.75 in its last earnings report, missing expectations of -$6.25. Following the earnings report the stock price went up 4.895%.
Which hedge fund is a major shareholder of Traws Pharma?
Currently, no hedge funds are holding shares in TRAW
---
Traws Pharma Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$7.00 (18.65% Upside)
$7.00 (18.65% Upside)
Crowd Wisdom
Very Positive
Last 7 Days ▲ 1.2%
Last 30 Days ▲ 11.1%
Last 30 Days ▲ 11.1%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-66.18%
12-Months-Change
Fundamentals
Return on Equity
-1096.52%
Trailing 12-Months
Asset Growth
-38.67%
Trailing 12-Months
Company Description
Traws Pharma
Onconova Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the identification and development of oncology therapeutics. It focuses on discovering and developing small molecule drug candidates to treat cancer. The company was founded by Ramesh Kumar and E. Premkumar Reddy on December 22, 1998 and is headquartered in Newtown, PA.
---
TRAW Earnings Call
Q2 2024
0:00 / 0:00
---
TRAW Stock 12 Month Forecast
Average Price Target
$7.00
▲(18.65% Upside)
Technical Analysis
Best Analysts Covering TRAW
1 Year
1 Year Success Rate
2/17 ratings generated profit
1 Year Average Return
-42.65%
reiterated a buy rating 2 months ago
Copying Robert LeBoyer's trades and holding each position for 1 Year would result in 11.76% of your transactions generating a profit, with an average return of -42.65% per trade.
---